Viewing Study NCT01540604


Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2026-02-21 @ 2:36 AM
Study NCT ID: NCT01540604
Status: COMPLETED
Last Update Posted: 2012-10-02
First Post: 2012-02-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers
Sponsor: RSPR Pharma AB
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Duchenne Muscular Dystrophy View
None Becker Muscular Dystrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DMD View
None BMD View
None symptomatic carriers View